| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A need to refine venous thromboembolism risk assessment: the challenge of optimizing patient selection for thromboprophylaxis among hospitalized adults
|
Schaefer, Jordan K.
|
|
|
7 |
8 |
p.
|
article
|
| 2 |
Antiphospholipid syndrome in rural, remote, and First Nations peoples in the Top End of the Northern Territory, Australia
|
Agbayani, Evangeline
|
|
|
7 |
8 |
p.
|
article
|
| 3 |
Artificial intelligence for venous thromboembolism prophylaxis: Clinician perspectives
|
Lam, Barbara D.
|
|
|
7 |
8 |
p.
|
article
|
| 4 |
Breakthrough infections after COVID-19 vaccinations do not elicit platelet hyperactivation and are associated with high platelet–lymphocyte and low platelet–neutrophil aggregates
|
Maiorca, Francesca
|
|
|
7 |
8 |
p.
|
article
|
| 5 |
Corrigendum to ‘Recurrent venous thromboembolism in hospitalized children with a history of prior venous thromboembolism: a report from the Children’s Hospital-Acquired Thrombosis Consortium’ [Research and Practice in Thrombosis and Haemostasis Volume 7, Issue 5, July 2023, 102139]
|
Wilson, Hope P.
|
|
|
7 |
8 |
p.
|
article
|
| 6 |
COVID-19. Comparison of D-dimer levels measured with 3 commercial platforms
|
Scalambrino, Erica
|
|
|
7 |
8 |
p.
|
article
|
| 7 |
D-dimer predicts venous thromboembolism in multiple myeloma: a nested case-control study
|
Sanfilippo, Kristen M.
|
|
|
7 |
8 |
p.
|
article
|
| 8 |
Editorial Board
|
|
|
|
7 |
8 |
p.
|
article
|
| 9 |
Effect of emicizumab-neutralizing antibodies on activated partial thromboplastin time–based clotting time test results in patients treated with emicizumab
|
Novembrino, Cristina
|
|
|
7 |
8 |
p.
|
article
|
| 10 |
Emicizumab use in females with moderate or mild hemophilia A without factor VIII inhibitors who warrant prophylaxis
|
Hermans, Cedric
|
|
|
7 |
8 |
p.
|
article
|
| 11 |
Factor IX administration in the skin primes inhibitor formation and sensitizes hemophilia B mice to systemic factor IX administration
|
Sherman, Alexandra
|
|
|
7 |
8 |
p.
|
article
|
| 12 |
Factors XI and XII in extracorporeal membrane oxygenation: longitudinal profile in children
|
Drop, Joppe
|
|
|
7 |
8 |
p.
|
article
|
| 13 |
Factor V Leiden interferes with protein S activity assay
|
Panaget, Baptiste
|
|
|
7 |
8 |
p.
|
article
|
| 14 |
Guiding warfarin self-management in children: development of a warfarin nomogram
|
Jones, Sophie
|
|
|
7 |
8 |
p.
|
article
|
| 15 |
Heavy menstrual bleeding in adolescents: a primary issue in primary care
|
Simoneau, Jillian
|
|
|
7 |
8 |
p.
|
article
|
| 16 |
Heparin-induced thrombocytopenia (and autoimmune heparin-induced thrombocytopenia): an illustrious review
|
Warkentin, Theodore E.
|
|
|
7 |
8 |
p.
|
article
|
| 17 |
How We Write a Manuscript Discussion
|
Gangaraju, Radhika
|
|
|
7 |
8 |
p.
|
article
|
| 18 |
Immune cell–mediated venous thrombus resolution
|
Henke, Peter K.
|
|
|
7 |
8 |
p.
|
article
|
| 19 |
Inhibitor development according to concentrate in severe hemophilia: reporting on 1392 Previously Untreated Patients from Europe and Canada
|
Fischer, Kathelijn
|
|
|
7 |
8 |
p.
|
article
|
| 20 |
Intracardiac thrombi in pediatrics: anticoagulation approach and treatment outcomes
|
Agarwal, Shreya
|
|
|
7 |
8 |
p.
|
article
|
| 21 |
Investigating patients for bleeding disorders when most of the “usual” ones have been ruled out
|
Mehic, Dino
|
|
|
7 |
8 |
p.
|
article
|
| 22 |
Issue Information
|
|
|
|
7 |
8 |
p.
|
article
|
| 23 |
Posttraumatic stress disorder and posttraumatic stress symptoms among adults with hemophilia A and B
|
Stahl, Amanda
|
|
|
7 |
8 |
p.
|
article
|
| 24 |
Race, ethnicity, and immune tolerance induction in hemophilia A in the United States
|
Kempton, Christine L.
|
|
|
7 |
8 |
p.
|
article
|
| 25 |
Reassessment of dextran sulfate in anti-Xa assay for unfractionated heparin laboratory monitoring
|
Hardy, Michael
|
|
|
7 |
8 |
p.
|
article
|
| 26 |
Serious bleeds in pediatric persons with hemophilia A on emicizumab prophylaxis
|
Garcia, Jessica
|
|
|
7 |
8 |
p.
|
article
|
| 27 |
Sex Matters: Policy on Reporting Sex as a Biological Variable at Research and Practice in Thrombosis and Hemostasis
|
Samuelson Bannow, Bethany
|
|
|
7 |
8 |
p.
|
article
|
| 28 |
The crux of menopausal hormone therapy: dose, route, and age
|
Hobbs, Linzi M.
|
|
|
7 |
8 |
p.
|
article
|
| 29 |
Therapeutic-dose heparin in preventing COVID-19–associated acute kidney injury: What about bleeding risk?
|
Kow, Chia Siang
|
|
|
7 |
8 |
p.
|
article
|
| 30 |
The World Federation of Hemophilia World Bleeding Disorders Registry: insights from the first 10,000 patients
|
Coffin, Donna
|
|
|
7 |
8 |
p.
|
article
|
| 31 |
Treatment of chemotherapy-induced thrombocytopenia with monotherapy versus combination therapy: the devil is in the details
|
Al-Samkari, Hanny
|
|
|
7 |
8 |
p.
|
article
|
| 32 |
Use of direct oral anticoagulants for venous thromboembolism treatment at extremes of body weight, renal and liver function: an illustrated review
|
Speed, Victoria
|
|
|
7 |
8 |
p.
|
article
|
| 33 |
Vaccine-induced immune thrombotic thrombocytopenia post COVID-19 booster vaccination in Brazil: a case series
|
Mendes-de-Almeida, Daniela P.
|
|
|
7 |
8 |
p.
|
article
|
| 34 |
Venous thromboembolism among physically active young adult females
|
Shapiro, Michael
|
|
|
7 |
8 |
p.
|
article
|
| 35 |
Western blot and immunohistochemical analysis of mouse tissue factor
|
Mackman, Nigel
|
|
|
7 |
8 |
p.
|
article
|
| 36 |
What can historical literature on von Willebrand disease teach us?
|
Thachil, Jecko
|
|
|
7 |
8 |
p.
|
article
|
Journal description